Clinical Trial Update: Effect of Tadalafil Administration on Vasodilatation Mediated by Flow in Patients With Obesity Grade I-II [Phase 3]

View source ↗

Summary

Phase 3 trial exploring whether tadalafil affects vasodilation mediated by flow in adults with obesity and erectile dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Obesity

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Centro Universitario de Ciencias de la Salud, Mexico | Conditions: Obesity and Erectile Dysfuntion | Phase 3 | Status: UNKNOWN